Cargando…
ERK inhibition sensitizes CZ415-induced anti-osteosarcoma activity in vitro and in vivo
mTOR is a valuable oncotarget for osteosarcoma. The anti-osteosarcoma activity by a novel mTOR kinase inhibitor, CZ415, was evaluated. We demonstrated that CZ415 potently inhibited survival and proliferation of known osteosarcoma cell lines (U2OS, MG-63 and SaOs2), and primary human osteosarcoma cel...
Autores principales: | Yin, Gang, Fan, Jin, Zhou, Wei, Ding, Qingfeng, Zhang, Jun, Wu, Xuan, Tang, Pengyu, Zhou, Hao, Wan, Bowen, Yin, Guoyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669867/ https://www.ncbi.nlm.nih.gov/pubmed/29137241 http://dx.doi.org/10.18632/oncotarget.18303 |
Ejemplares similares
-
Status report on experiment R415
por: Basile, M, et al.
Publicado: (1978) -
Lattice sites and stability of implanted Er in FZ and CZ Si
por: Wahl, U, et al.
Publicado: (2003) -
Atlas Tile Calorimeter submodules assembly in Prague, CZ 1999
por: Nessi, M
Publicado: (1999) -
Metabolic Difference of CZ48 in Human and Mouse Liver Microsomes
por: Liu, Xing, et al.
Publicado: (2012) -
Lack of endogenous parathyroid hormone delays fracture healing by inhibiting vascular endothelial growth factor-mediated angiogenesis
por: Ding, Qingfeng, et al.
Publicado: (2018)